Celestica Balance Sheet Health
Financial Health criteria checks 6/6
Celestica has a total shareholder equity of $1.8B and total debt of $733.9M, which brings its debt-to-equity ratio to 40.3%. Its total assets and total liabilities are $5.9B and $4.1B respectively. Celestica's EBIT is $514.6M making its interest coverage ratio 8.9. It has cash and short-term investments of $398.5M.
Key information
40.3%
Debt to equity ratio
US$733.90m
Debt
| Interest coverage ratio | 8.9x |
| Cash | US$398.50m |
| Equity | US$1.82b |
| Total liabilities | US$4.11b |
| Total assets | US$5.93b |
Recent financial health updates
No updates
Recent updates
Celestica: AI Capex Boom Still Promising, Baked-In Premium Triggers Downgrade
Nov 04Celestica Q3: Defying Expectations With Undemanding Valuations
Oct 24Celestica: Still A Value Buy Despite The Recent Recovery
Oct 12Celestica: Institutional Investors Are Buying, So Am I
Sep 27Celestica: Weak Bargaining Power, Hold For Now
Sep 04Celestica: Bullish Expectations May Be Priced In
Aug 19Celestica: Q2 2024, Why Do I Upgrade The Stock To 'Buy' Again
Aug 02Celestica Stock Has Only Become Cheaper -- 'Buy' Before Earnings Release
Jul 23Celestica's AI Pivot Will Continue To Fuel Its 300% Risky Rally
Jul 11Celestica: High Quant Rating Looks Well-Deserved
Jun 25Assessing Celestica's Near-Term Prospects Given Meteoric Rise
Jun 10Celestica: An AI Play With Significant Upside
May 27Celestica: Explosive Momentum And Growth At An Attractive Price (SA Quant)
May 03Celestica: Time To Load Up
Apr 22Celestica: AI Wave Caution
Mar 18Celestica: A Deep Dive Into A Mysterious Grower
Mar 11Celestica: Why I'm Buying This Stock
Feb 15Celestica: Strong Q4 Earnings, Reiterate Buy
Feb 02Celestica: Why It Remains A Long-Term Strong Buy
Jan 14Why Celestica Stock Is A Buy Into Q4 Earnings
Jan 03Why Celestica Remains Among The Top Rated Stocks Heading Into 2024
Dec 13Celestica: Still A Bargain At Current Levels
Dec 04Riding The Celestica Wave: Q3 Earnings, Buyback Plans, And Future Forecasts
Nov 16Why Celestica Stock Could Be A Potential Double Within The Next 2-3 Years
Nov 06Celestica's Next Pullback Offers A Buy With Strong Fundamentals
Oct 16Celestica: Still Bullish After Strong Upside
Oct 06Celestica: Momentum Gone
Sep 14Celestica: A Top-Rated Stock To Keep An Eye On
Aug 03Celestica: Undervalued With Solid Revenue Growth
May 29Celestica Non-GAAP EPS of $0.56 beats by $0.02, revenue of $2.04B beats by $80M
Jan 25Why Celestica Is A Top 2023 Pick
Dec 09Financial Position Analysis
Short Term Liabilities: CLS's short term assets ($4.5B) exceed its short term liabilities ($3.0B).
Long Term Liabilities: CLS's short term assets ($4.5B) exceed its long term liabilities ($1.1B).
Debt to Equity History and Analysis
Debt Level: CLS's net debt to equity ratio (18.4%) is considered satisfactory.
Reducing Debt: CLS's debt to equity ratio has reduced from 43.9% to 40.3% over the past 5 years.
Debt Coverage: CLS's debt is well covered by operating cash flow (73.3%).
Interest Coverage: CLS's interest payments on its debt are well covered by EBIT (8.9x coverage).